Centrosome amplification as a putative prognostic biomarker for the classification of urothelial carcinomas

Human Pathology

Volumn 42, Issue 12, 2011, Pages 1923-1930

  Yamamoto, Yoshiaki ^a   Misumi, Taku ^a   Eguchi, Satoshi ^a   Chochi, Yasuyo ^a   Kitahara, Seiji ^a   Nakao, Motonao ^a   Nagao, Kazuhiro ^a   Hara, Takahiko ^a   Sakano, Shigeru ^a   Furuya, Tomoko ^a   Oga, Atsunori ^a   Kawauchi, Shigeto ^a   Sasaki, Kohsuke ^a   Matsuyama, Hideyasu ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Array based comparative genomic hybridization; Centrosome amplification; Chromosomal instability; DNA copy number aberrations; Urothelial carcinoma

Indexed keywords

GAMMA TUBULIN; GAMMA TUBULIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CENTROSOME; CHROMOSOMAL INSTABILITY; CHROMOSOME 17; CHROMOSOME 7; CHROMOSOME 9; COPY NUMBER VARIATION; DISEASE CLASSIFICATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; TRANSITIONAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CENTROSOME; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 7; CHROMOSOMES, HUMAN, PAIR 9; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 80955165981     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.02.013     Document Type: Article

References (37)

1. F.K. Mostofi, L.H. Sobin, and H. Torloni Histological typing of urinary bladder tumors 1973 World Health Organization Geneva
2. J.N. Eble, G. Sauter, J.I. Epstein, and I.A. Sesterhenn Tumours of the urinary system and male genital organs 2004 World Health Organization Classification of Tumours
3. S. Holmang, and S.L. Johansson Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system Urology 66 2005 274 278 (Pubitemid 41138081)
4. H. Miyamoto, J.S. Miller, D.A. Fajardo, T.K. Lee, G.J. Netto, and J.I. Epstein Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system Pathol Int 60 2010 1 8
5. M. May, S. Brookman-Amissah, and J. Roigas Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 world health organisation classifications Eur Urol 57 2010 850 858
6. C. Lengauer, K.W. Kinzler, and B. Vogelstein Genetic instability in colorectal cancers Nature 386 1997 623 627 (Pubitemid 27175430)
7. K. Ikemoto, T. Furuya, and K. Matsuda Multicolor FISH and cytometric analyses allow classification of urothelial carcinomas into two subtypes, low- and high-grade tumors Int J Oncol 25 2004 893 898
8. Y. Yamamoto, H. Matsuyama, and S. Kawauchi Biological characteristics in bladder cancer depend on the type of genetic instability Clin Cancer Res 12 2006 2752 2758
9. H. Rajagopalan, M.A. Nowak, B. Vogelstein, and C. Lengauer The significance of unstable chromosomes in colorectal cancer Nat Rev Cancer 3 2003 695 701 (Pubitemid 37328824)
10. S. Kawauchi, T. Furuya, and K. Ikemoto DNA copy number aberrations associated with aneuploidy and chromosomal instability in breast cancers Oncol Rep 24 2010 875 883
11. K. Fukasawa Centrosome amplification, chromosome instability and cancer development Cancer Lett 230 2005 6 19 (Pubitemid 41506955)
12. W.L. Lingle, S.L. Barrett, and V.C. Negron Centrosome amplification drives chromosomal instability in breast tumor development Proc Natl Acad Sci U S A 99 2002 1978 1983 (Pubitemid 34169000)
13. G.A. Pihan, J. Wallace, Y. Zhou, and S.J. Doxsey Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas Cancer Res 63 2003 1398 1404 (Pubitemid 36348723)
14. J. Akao, H. Matsuyama, Y. Yamamoto, K. Sasaki, and K. Naito Chromosome 20q13.2 gain may predict intravesical recurrence after nephroureterectomy in upper urinary tract urothelial tumors Clin Cancer Res 12 2006 7004 7008 (Pubitemid 44974496)
15. K. Kawamura, M. Moriyama, and N. Shiba Centrosome hyperamplification and chromosomal instability in bladder cancer Eur Urol 43 2003 505 515 (Pubitemid 36528437)
16. Y. Yamamoto, H. Matsuyama, and T. Furuya Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer Clin Cancer Res 10 2004 6449 6455 (Pubitemid 39346539)
17. D. Pinkel, R. Segraves, and D. Sudar High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays Nat Genet 20 1998 207 211 (Pubitemid 28455458)
18. Y. Chochi, S. Kawauchi, and M. Nakao A copy number gain of the 6p arm is linked with advanced hepatocellular carcinoma: an array-based comparative genomic hybridization study J Pathol 217 2009 677 684
19. T. Furuya, T. Uchiyama, and A. Adachi The development of a mini-array for estimating the disease state of gastric adenocarcinoma by array CGH BMC Cancer 8 2008 393
20. M. Nakao, S. Kawauchi, and T. Furuya Identification of DNA copy number aberrations associated with metastases of colorectal cancer using array CGH profiles Cancer Genet Cytogenet 188 2009 70 76
21. E. Blaveri, J.L. Brewer, and R. Roydasgupta Bladder cancer stage and outcome by array-based comparative genomic hybridization Clin Cancer Res 11 2005 7012 7022 (Pubitemid 41428761)
22. J.A. Veltman, J. Fridlyand, and S. Pejavar Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors Cancer Res 63 2003 2872 2880 (Pubitemid 36667159)
23. M. Heidenblad, D. Lindgren, and T. Jonson Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors BMC Med Genomics 1 2008 3
24. S. Eguchi, Y. Yamamoto, and S. Sakano The loss of 8p23.3 is a novel marker for predicting progression and recurrence of bladder tumors without muscle invasion Cancer Genet Cytogenet 200 2010 16 22
25. L. Sobin, and C. Wittekind UICC TNM classification of malignant tumors 6th ed. Revised 2002 Wiley New York 199 202
26. M. Okuda, H.F. Horn, and P. Tarapore Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication Cell 103 2000 127 140
27. K. Matsuda, H. Matsuyama, and T. Hara DNA sequence copy number aberrations in prostate cancers: a comparison of comparative genomic hybridization data between Japan and European countries Cancer Genet Cytogenet 152 2004 119 123 (Pubitemid 38953012)
28. Y. Yamamoto, Y. Chochi, and H. Matsuyama Gain of 5p15.33 is associated with progression of bladder cancer Oncology 72 2007 132 138 (Pubitemid 350249141)
29. W.M. Murphy, K. Takezawa, and N.A. Maruniak Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic Pathology classification of urothelial neoplasms: practical choices for patient care J Urol 168 2002 968 972
30. M.G. Bol, J.P. Baak, and S. Buhr-Wildhagen Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder J Urol 169 2003 1291 1294 (Pubitemid 36323769)
31. P.A. Campbell, R.J. Conrad, C.M. Campbell, D.L. Nicol, and P. MacTaggart Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome BJU Int 93 2004 1228 1231 (Pubitemid 38823942)
32. I.I. Gonul, A. Poyraz, C. Unsal, C. Acar, and T. Alkibay Comparison of 1998 WHO/ISUP and 1973 WHO classifications for interobserver variability in grading of papillary urothelial neoplasms of the bladder. Pathological evaluation of 258 cases Urol Int 78 2007 338 344 (Pubitemid 46725706)
33. L.M. Gustafson, L.L. Gleich, and K. Fukasawa Centrosome hyperamplification in head and neck squamous cell carcinoma: a potential phenotypic marker of tumor aggressiveness Laryngoscope 110 2000 1798 1801
34. W.J. Chng, E. Braggio, and G. Mulligan The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibition Blood 111 2008 1603 1609 (Pubitemid 351213451)
35. M.I. Syed, S. Syed, and F. Minty Gamma tubulin: a promising indicator of recurrence in squamous cell carcinoma of the larynx Otolaryngol Head Neck Surg 140 2009 498 504
36. H. Matsuyama, U.S. Bergerheim, and I. Nilsson Nonrandom numerical aberrations of chromosomes 7, 9, and 10 in DNA-diploid bladder cancer Cancer Genet Cytogenet 77 1994 118 124
37. M. Tsukamoto, H. Matsuyama, K. Oba, S. Yoshihiro, M. Takahashi, and K. Naito Numerical aberrations of chromosome 9 in bladder cancer. A possible prognostic marker for early tumor recurrence Cancer Genet Cytogenet 134 2002 41 45 (Pubitemid 34462108)